Precise identification of DMD mutations and their consequences on mRNA and protein expression is essential to provide accurate genetic counseling in dystrophinopathy families and to include patients in mutation suppression therapies. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.